Form 497VPI Nationwide Variable Acco
Tweet
Share
E-mailSupplement dated January
15, 2025
to the following initial summary prospectus(es):
to the following initial summary prospectus(es):
BOA IV, Nationwide Destination B (2.0), Nationwide Destination B NY (2.0), Nationwide
Destination Navigator (2.0), Nationwide Destination Navigator NY (2.0), Nationwide Destination All American
Gold (2.0), Nationwide Destination Architect 2.0, BOA V, Nationwide Advisory Retirement Income Annuity and Nationwide Advisory Retirement Income Annuity - New York prospectus dated May 1, 2024
| This supplement updates certain information contained in your initial summary prospectus. Please read and
retain this supplement for future reference. |
The Board of Trustees of the Goldman Sachs Variable Insurance Trust
approved to liquidate the Goldman Sachs Variable Insurance Trust - Goldman Sachs Multi-Strategy Alternatives Portfolio: Service Shares (the "Liquidating Fund"). The liquidation is expected to occur on or about April 11, 2025 (the "Liquidation Date").
In anticipation of the liquidation, the following changes apply to the
contract:
•
Effective April 7, 2025, the Liquidating Fund is no longer available to receive transfers or new purchase
payments.
•
From the date of this supplement until the Liquidation Date, investors with allocations in the
Liquidating Fund may transfer allocations to any other available investment option. During this period, any transfers from the Liquidating Fund will not be treated as a transfer for purposes of transfer limitations that would otherwise be
applicable.
•
On the Liquidation Date, any remaining assets of the Liquidating Fund will be transferred to
Nationwide Variable Insurance Trust - NVIT Government Money Market Fund: Class I.
•
After the Liquidation Date, any and all references to the Liquidating Fund are
deleted.
ISP-0835
1
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zoomex X Space Recap With David James and the World Cup Trading Panel
- Xeltis makes first commercial implant of aXess™, its vascular access device for hemodialysis
- Capvidia Announces 2026 R1 Software Release to Strengthen MBD Readiness, QIF Workflows, and Digital Thread Automation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
